Earnings Report

Chinese e-commerce firm Alibaba on Thursday reported a 55 percent rise in second-quarter revenue, beating analyst estimates.

Yelp Inc. (YELP) on Wednesday reported third-quarter net income of $2.1 million, after reporting a loss in the same period a year earlier.

Yelp Inc. (YELP) on Wednesday reported third-quarter net income of $2.1 million, after reporting a loss in the same period a year earlier.

Alibaba Group Holding Ltd. (BABA) on Wednesday reported fiscal second-quarter earnings of $1.14 billion.

Alibaba Group Holding Ltd. (BABA) on Wednesday reported fiscal second-quarter earnings of $1.14 billion.

Time Warner the media company being bought by AT&T, reported a 9.2 percent rise in quarterly revenue on Wednesday.

Time Warner the media company being bought by AT&T, reported a 9.2 percent rise in quarterly revenue on Wednesday.

Office Depot Inc. (ODP) on Wednesday reported third-quarter profit of $44 million.

Office Depot Inc. (ODP) on Wednesday reported third-quarter profit of $44 million.

Kate Spade & Co. (KATE) on Wednesday reported third-quarter profit of $29.6 million.

Kate Spade & Co. (KATE) on Wednesday reported third-quarter profit of $29.6 million.

Shares in Danish conglomerate A.P.

Shares in Danish conglomerate A.P.

Tesla says solar panel maker SolarCity Corp. could add $1 billion in revenue next year if the two companies merge.

Tesla says solar panel maker SolarCity Corp. could add $1 billion in revenue next year if the two companies merge.

Further broadening its reach beyond electric cars, Tesla Motors says it's going to sell solar roof tiles that are customizable and meant to look like a traditional roof.

Further broadening its reach beyond electric cars, Tesla Motors says it's going to sell solar roof tiles that are customizable and meant to look like a traditional roof.

Drugmaker Pfizer topped off a difficult third quarter with news that it's scrapping a closely watched experimental cholesterol drug, partly due to expectations insurers would limit access so much that it wouldn't make much money, a possible bad omen for the pharmaceutical industry.

Drugmaker Pfizer topped off a difficult third quarter with news that it's scrapping a closely watched experimental cholesterol drug, partly due to expectations insurers would limit access so much that it wouldn't make much money, a possible bad omen for the pharmaceutical industry.

Two of Europe's largest energy companies said Tuesday that low oil prices weighed on underlying earnings once again in the third quarter and predicted that the price backdrop won't be returning to the heights seen as recently as 2014 anytime soon.